Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Epperly Melissa B,
Over the trailing 90 days, Epperly Melissa B, (Director at Roivant Sciences Ltd.) traded $689K of stock (net selling $531K) across 2 companies, per 6 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 6 transactions · CIK 1807359
- Net activity
- −$531K ($79K bought · $610K sold)
By Company (Trailing 90 Days)
Transactions (6)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-17 | ROIV | Buy | 543 | $0 | Grant, award or other acquisition |
| 2026-06-29 | ROIV | Sell | 2.7K | $95K | Open market or private sale |
| 2026-06-29 | ROIV | Sell | 15.0K | $515K | Open market or private sale |
| 2026-06-29 | ROIV | Buy | 17.8K | $79K | Exercise or conversion of derivative security |
| 2026-06-29 | ROIV | Sell | 17.8K | $0 | Exercise or conversion of derivative security |
| 2026-06-18 | NAUT | Buy | 45.0K | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Epperly's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.